No neurofibrillary tangles or amyloid plaques were found in the parenchyma ... magnetic gait and hypertonia of the extremities, treatment with dexamethasone (2 × 4 mg/day) was started.

Brazil's National Health Surveillance Agency (Anvisa) has approved the use of the drug donanemabe to slow the progression of ...

Researchers at the University of California, Irvine, have developed a groundbreaking therapy for Alzheimer’s disease by using ...

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help ... people with underlying ...

ALNY is developing investigational RNAi therapeutic, mivelsiran, for the treatment of Alzheimer’s disease and cerebral ...

“Improving neurovascular integrity and BBB function in AD are important targets and may offer additive or synergistic treatment ... referred to as cerebral amyloid angiopathy (CAA).

These results corroborate clearance of amyloid-β deposits after initial treatment of the cortex with direct application of 10D5. Figure 4: Histological analysis of imaged brains from 20-month-old ...

Histological examination shows amyloid-laden vessels and the appearance ... appears to derive a beneficial effect from corticosteroid treatment. This effect could be dependant on the pathological ...